cfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infections in general practice: a study protocol for a prospective cohort study.
Saved in:
| Title: | cfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infections in general practice: a study protocol for a prospective cohort study. |
|---|---|
| Authors: | Dehnen D; Institute of General Practice, Medical Faculty, University of Duisburg-Essen Faculty of Medicine, Essen, Germany., Neuberger E; Department of Sports Medicine, Rehabilitation and Disease Prevention, Johannes Gutenberg Universitat Mainz, Mainz, Germany., In der Schmitten J; Institute of General Practice, Medical Faculty, University of Duisburg-Essen Faculty of Medicine, Essen, Germany., Giagkou E; Institute of General Practice, Medical Faculty, University of Duisburg-Essen Faculty of Medicine, Essen, Germany., Simon P; Department of Sports Medicine, Rehabilitation and Disease Prevention, Johannes Gutenberg Universitat Mainz, Mainz, Germany., Botzenhardt S; Institute of General Practice, Medical Faculty, University of Duisburg-Essen Faculty of Medicine, Essen, Germany Suzan.Botzenhardt@uk-essen.de. |
| Source: | BMJ open [BMJ Open] 2022 Jun 16; Vol. 12 (6), pp. e058647. Date of Electronic Publication: 2022 Jun 16. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2044-6055 |
|---|---|
| DOI: | 10.1136/bmjopen-2021-058647 |
